XML 19 R8.htm IDEA: XBRL DOCUMENT v3.24.1.u1
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Millions
Total
Restricted stock units
Total stockholders’ equity attributable to T. Rowe Price Group, Inc.
Total stockholders’ equity attributable to T. Rowe Price Group, Inc.
Restricted stock units
Common stock
Common stock
Restricted stock units
Additional capital in excess of par value
Additional capital in excess of par value
Restricted stock units
Retained earnings
AOCI
 [1]
Non-controlling interests in consolidated entities
Beginning balance (in shares) at Dec. 31, 2022         224,310,000            
Balances at beginning of period at Dec. 31, 2022 $ 9,030.2   $ 8,839.5   $ 44.9   $ 437.9   $ 8,409.7 $ (53.0) $ 190.7
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net income (loss) 425.0   421.5           421.5   3.5
Other comprehensive income (loss), net of tax 1.3   1.3             1.3  
Dividends declared (280.7)   (280.7)           (280.7)    
Shares issued upon option exercises (in shares)         190,000            
Shares issued upon option exercises 10.2   10.2       10.2        
Net shares issued upon vesting of restricted stock units (in shares)           52,000          
Net shares issued upon vesting of restricted stock units   $ (2.5)   $ (2.5)       $ (2.5)      
Stock-based compensation expense 58.8   58.8       58.8        
Restricted stock units issued as dividend equivalents 0.0   0.0       0.1   (0.1)    
Common shares repurchased (in shares)         (25,000)            
Common shares repurchased (2.7)   (2.7)       (2.7)        
Net contributions to non-controlling interests in consolidated entities 0.2                   0.2
Ending balance (in shares) at Mar. 31, 2023         224,527,000            
Balances at end of period at Mar. 31, 2023 9,239.8   9,045.4   $ 44.9   501.8   8,550.4 (51.7) 194.4
Beginning balances attributable to redeemable non-controlling interests at Dec. 31, 2022 656.7                    
Increase (Decrease) in Temporary Equity [Roll Forward]                      
Net income (loss) 20.2                    
Other comprehensive income (loss), net of tax 6.1                    
Net subscriptions into T. Rowe Price investment products 151.1                    
Ending balances attributable to redeemable non-controlling interests at Mar. 31, 2023 834.1                    
Beginning balance (in shares) at Dec. 31, 2023         223,938,000            
Balances at beginning of period at Dec. 31, 2023 9,697.1   9,505.1   $ 44.8   431.7   9,076.1 (47.5) 192.0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net income (loss) 587.0   573.8           573.8   13.2
Other comprehensive income (loss), net of tax (2.1)   (2.1)             (2.1)  
Dividends declared $ (285.0)   (285.0)           (285.0)    
Shares issued upon option exercises (in shares) 348,728       246,000            
Shares issued upon option exercises $ 15.4   15.4       15.4        
Net shares issued upon vesting of restricted stock units (in shares)           27,000          
Net shares issued upon vesting of restricted stock units   $ (1.4)   $ (1.4)       $ (1.4)      
Stock-based compensation expense 58.4   58.4       58.4        
Restricted stock units issued as dividend equivalents 0.0           0.1   (0.1)    
Common shares repurchased (in shares)         (717,000)            
Common shares repurchased (80.1)   (80.1)   $ (0.1)   (80.0)        
Net contributions to non-controlling interests in consolidated entities 0.2                   0.2
Ending balance (in shares) at Mar. 31, 2024         223,494,000            
Balances at end of period at Mar. 31, 2024 9,989.5   $ 9,784.1   $ 44.7   $ 424.2   $ 9,364.8 $ (49.6) $ 205.4
Beginning balances attributable to redeemable non-controlling interests at Dec. 31, 2023 594.1                    
Increase (Decrease) in Temporary Equity [Roll Forward]                      
Net income (loss) 19.6                    
Other comprehensive income (loss), net of tax (1.6)                    
Net subscriptions into T. Rowe Price investment products 92.7                    
Net deconsolidations of T. Rowe Price investment products (28.1)                    
Ending balances attributable to redeemable non-controlling interests at Mar. 31, 2024 $ 676.7                    
[1] Accumulated other comprehensive income